Insider Trading & Ownership - Dubois-Stringfellow Nathalie

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Dubois-Stringfellow Nathalie

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-24
Tax Withholding
2024-08-27
4:37 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
3,295$0.86844,598
(Direct)
View
2024-05-24
Tax Withholding
2024-05-29
5:18 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
3,295$0.6842,893
(Direct)
View
2024-02-24
Tax Withholding
2024-02-27
5:13 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
10,484$1.13846,188
(Direct)
View
2024-01-22
Option Award
2024-01-24
4:40 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
712,500$0856,672
(Direct)
View
2023-11-25
Tax Withholding
2023-11-28
4:16 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-Chief Development Officer
1,462$0.3821139,172
(Direct)
View
2023-08-25
Tax Withholding
2023-08-29
4:13 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-Chief Development Officer
1,462$0.77140,634
(Direct)
View
2023-05-25
Tax Withholding
2023-05-30
4:43 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-Chief Development Officer
1,462$1.33137,096
(Direct)
View
2023-02-25
Tax Withholding
2023-03-06
5:08 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-Chief Development Officer
9,834$2.66387,933
(Direct)
View
2023-02-24
Option Award
2023-03-06
5:08 pm
N/A
2033-02-23
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-Chief Development Officer
302,813$0387,933
(Direct)
View

Ownership
2022-09-19
7:24 pm
N/A
N/A
SANGAMO THERAPEUTICS INCSGMODubois-Stringfellow Nathalie
SVP-Chief Development Officer
0$0419,581
(Direct)
View